Page last updated: 2024-09-03

elacridar and Cancer of Prostate

elacridar has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corcoran, C; Devery, A; Dowling, C; Fan, Y; Fitzpatrick, JM; Gallagher, WM; Mulrane, L; O'Connor, D; O'Connor, R; O'Driscoll, L; O'Neill, AJ; Prencipe, M; Rani, S; Watson, RW1

Other Studies

1 other study(ies) available for elacridar and Cancer of Prostate

ArticleYear
Characterisation and manipulation of docetaxel resistant prostate cancer cell lines.
    Molecular cancer, 2011, Oct-07, Volume: 10

    Topics: Acridines; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; ATP Binding Cassette Transporter, Subfamily B, Member 1; beta-Galactosidase; Cell Line, Tumor; Cell Survival; Cellular Senescence; Docetaxel; Drug Resistance, Neoplasm; Gene Expression; Gene Expression Profiling; Genes, Reporter; Humans; Luciferases, Renilla; Male; Molecular Targeted Therapy; NF-kappa B; Nitriles; Prostatic Neoplasms; Sulfones; Taxoids; Tetrahydroisoquinolines

2011